Eley Financial Management Inc purchased a new stake in The Procter & Gamble Company (NYSE:PG – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 5,000 shares of the company’s stock, valued at approximately $838,000.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Procter & Gamble by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 229,794,073 shares of the company’s stock worth $38,524,976,000 after acquiring an additional 1,592,061 shares during the period. Geode Capital Management LLC grew its holdings in Procter & Gamble by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 56,472,195 shares of the company’s stock valued at $9,457,000,000 after buying an additional 1,267,419 shares during the last quarter. Norges Bank acquired a new position in shares of Procter & Gamble during the fourth quarter worth approximately $5,244,463,000. Franklin Resources Inc. grew its stake in shares of Procter & Gamble by 6.4% in the fourth quarter. Franklin Resources Inc. now owns 20,197,996 shares of the company’s stock worth $3,386,194,000 after acquiring an additional 1,209,275 shares during the last quarter. Finally, Fisher Asset Management LLC raised its stake in Procter & Gamble by 1.7% during the 4th quarter. Fisher Asset Management LLC now owns 18,692,813 shares of the company’s stock valued at $3,133,850,000 after purchasing an additional 312,203 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
A number of research analysts have recently commented on the stock. DA Davidson reaffirmed a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research report on Thursday, January 23rd. Wells Fargo & Company lifted their price objective on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a report on Thursday, January 23rd. Barclays reiterated an “equal weight” rating on shares of Procter & Gamble in a research note on Thursday, March 27th. JPMorgan Chase & Co. decreased their target price on shares of Procter & Gamble from $181.00 to $172.00 and set an “overweight” rating on the stock in a research report on Friday. Finally, UBS Group reiterated a “buy” rating on shares of Procter & Gamble in a research note on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $181.50.
Read Our Latest Stock Analysis on PG
In other Procter & Gamble news, CEO Gary A. Coombe sold 18,000 shares of the firm’s stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the transaction, the chief executive officer now owns 22,051 shares in the company, valued at approximately $3,785,274.66. This trade represents a 44.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the business’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares of the company’s stock, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 143,450 shares of company stock worth $23,988,008 in the last quarter. 0.18% of the stock is owned by company insiders.
Shares of PG traded up $3.40 during mid-day trading on Friday, hitting $166.96. 8,602,709 shares of the company traded hands, compared to its average volume of 7,038,790. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business has a 50-day moving average of $168.35 and a 200 day moving average of $168.62. The Procter & Gamble Company has a one year low of $153.52 and a one year high of $180.43. The stock has a market capitalization of $391.50 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 3.76 and a beta of 0.43.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.84 earnings per share. As a group, equities analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Monday, April 21st will be paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.53%. The ex-dividend date of this dividend is Monday, April 21st. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.01. Procter & Gamble’s dividend payout ratio (DPR) is 67.20%.
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- 3 Best Fintech Stocks for a Portfolio Boost
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- Stock Sentiment Analysis: How it Works
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- What is a Special Dividend?
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Before you consider Procter & Gamble, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Procter & Gamble wasn’t on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools.
Featured By
345 N Reid Place, Suite 620, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© MarketBeat Media, LLC 2010-2025. All rights reserved.
© 2025 Fair market value prices are updated every minute and are provided by Polygon.io. Other market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
My Account –
